Tissue Engineering: Current Technology for Facial Reconstruction.


Journal

Facial plastic surgery : FPS
ISSN: 1098-8793
Titre abrégé: Facial Plast Surg
Pays: United States
ID NLM: 8405303

Informations de publication

Date de publication:
Oct 2023
Historique:
medline: 25 9 2023
pubmed: 9 6 2023
entrez: 8 6 2023
Statut: ppublish

Résumé

Facial reconstruction is a complex surgical process that requires intricate three-dimensional (3D) concepts for optimal functional and aesthetic outcomes. Conventional reconstruction of structural facial anomalies, such as those including cartilage or bony defects, typically rely on hand-carving autologous constructs harvested from a separate donor site, and shaping that cartilage or bone into a new structural framework. Tissue engineering has emerged in recent decades as a potential approach to mitigate the need for donor site morbidity while improving precision in the design of reconstructive construct. Computer-aided design and computer-aided manufacturing have allowed for a digital 3D workflow to digitally execute the planned reconstruction in virtual space. 3D printing and other manufacturing techniques can then be utilized to create custom-fabricated scaffolds and guides to improve the reconstructive efficiency. Tissue engineering can be paired with custom 3D-manufactured scaffolds to theoretically create an ideal framework for structural reconstruction. In the past decade, there have been several compelling preclinical studies demonstrating the capacity to induce chondrogenesis or osteogenesis in a custom scaffold. However, to date, these preclinical data have not yet translated into significant clinical experience. This translation has been hindered by a lack of consensus on the ideal materials and cellular progenitors to be utilized in these constructs and a lack of regulatory guidance and control to enable clinical application. In this review, we highlight the current state of tissue engineering in facial reconstruction and exciting potential for future applications as the field continues to advance.

Identifiants

pubmed: 37290454
doi: 10.1055/s-0043-1769808
doi:

Types de publication

Review Journal Article

Langues

eng

Pagination

489-495

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

None declared.

Auteurs

Rachel Fenberg (R)

School of Medicine, Albert Einstein College of Medicine, Bronx, New York.

Natalia vonWindheim (N)

Center for Design and Manufacturing Excellence, The Ohio State University College of Engineering, Columbus, Ohio.

Megan Malara (M)

Center for Design and Manufacturing Excellence, The Ohio State University College of Engineering, Columbus, Ohio.

Maariyah Ahmed (M)

Center for Design and Manufacturing Excellence, The Ohio State University College of Engineering, Columbus, Ohio.

Erin Cowen (E)

Center for Design and Manufacturing Excellence, The Ohio State University College of Engineering, Columbus, Ohio.

Luigi Melaragno (L)

Center for Design and Manufacturing Excellence, The Ohio State University College of Engineering, Columbus, Ohio.

Kyle Vankoevering (K)

Department of Otolaryngology-Head and Neck Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH